Altesa BioSciences closed an oversubscribed $75 million Series B financing led by Forbion with participation from Sanofi to advance vapendavir, a first-in-class oral antiviral targeting rhinovirus infections in COPD patients.
A 24-year-old woman with refractory lupus achieved two successful pregnancies following dual-target CAR-T cell therapy, while bispecific T cell engagers showed efficacy in treatment-refractory antisynthetase syndrome and systemic sclerosis patients.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07381881 |
GEL-AID: Safe and Effective Hydration for Institutionalized Older Adults |
NOT_YET_RECRUITING | NA |
| NCT07352462 |
Volatile Organic Compounds Analysis by GC-MS for Diagnostic of Hospitalised Patients With Respiratory Infections Using Exhaled Breath |
NOT_YET_RECRUITING | NA |
| NCT07314593 |
Omega-Cold Supplementation With Free Fatty Acids for the Prevention of Respiratory Infections in Adults. |
NOT_YET_RECRUITING | NA |
| NCT07243249 |
Study Evaluating the Impact of Using Triplex Rapid Diagnostic Tests (SARS-CoV-2/Influenza/RSV) on Antibiotic Prescribing |
RECRUITING | NA |
| NCT06764381 |
Study of Viral Respiratory Infections |
NOT_YET_RECRUITING | |
| NCT05474430 |
Estimating Risk of Respiratory Infections Attributable to CFTR Heterozygosity |
RECRUITING | |
| NCT04362059 |
A Clinical Trial of Nebulized Surfactant for the Treatment of Moderate to Severe COVID-19 |
COMPLETED | NA |
| NCT03093220 |
Molecular Typing of Community-acquired Pneumonia Based on Multiple-omic Data Analysis |
UNKNOWN | |
| NCT02927743 |
Effect of Evidence-based Reminders on Use of Antibiotics |
COMPLETED | NA |
| NCT02491164 |
Exploratory Study of Intrapulmonary Microdosing of Gram-negative Optical Imaging Detection Probe |
COMPLETED | EARLY_PHASE1 |
